HIGH-RISK NEUROBLASTOMA
Clinical trials for HIGH-RISK NEUROBLASTOMA explained in plain language.
Never miss a new study
Get alerted when new HIGH-RISK NEUROBLASTOMA trials appear
Sign up with your email to follow new studies for HIGH-RISK NEUROBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising new combo therapy for tough childhood cancer
Disease control OngoingThis study tested whether adding two immunotherapy drugs (dinutuximab and GM-CSF) to standard chemotherapy is safe and feasible for children newly diagnosed with high-risk neuroblastoma, a rare and aggressive nerve cell cancer. About 42 children participated. The goal was to see …
Matched conditions: HIGH-RISK NEUROBLASTOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 07:18 UTC
-
New pill aims to keep high-risk childhood cancer at bay after immunotherapy
Disease control OngoingThis study tests whether the drug eflornithine, taken as a pill after standard immunotherapy, can help children with high-risk neuroblastoma live longer without the cancer coming back. About 20 children under 18 who have finished initial treatment and show minimal disease will ta…
Matched conditions: HIGH-RISK NEUROBLASTOMA
Sponsor: Shanghai Children's Hospital • Aim: Disease control
Last updated May 20, 2026 11:57 UTC
-
New hope for kids with tough neuroblastoma: adding DFMO to standard therapy
Disease control OngoingThis study tests whether adding a drug called eflornithine (DFMO) to a standard treatment (irinotecan, temozolomide, and dinutuximab) helps children with neuroblastoma that has come back or is not responding to treatment. About 94 children will be randomly assigned to receive the…
Matched conditions: HIGH-RISK NEUROBLASTOMA
Phase: PHASE2 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated May 19, 2026 12:00 UTC
-
Can we spot late side effects in neuroblastoma survivors? new study aims to find out
Knowledge-focused OngoingThis study looks at whether it's possible to screen for long-term health problems in people who survived high-risk neuroblastoma. Researchers will evaluate survivors who finished treatment at least 2 years ago. The goal is to see if a comprehensive checkup program is practical an…
Matched conditions: HIGH-RISK NEUROBLASTOMA
Sponsor: St. Jude Children's Research Hospital • Aim: Knowledge-focused
Last updated May 19, 2026 11:49 UTC